(INGR) Ingredion - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4571871023

Sweeteners, Starches, Nutrition Ingredients, Biomaterials, Corn Oil

INGR EPS (Earnings per Share)

EPS (Earnings per Share) of INGR over the last years for every Quarter: "2020-03": 1.1061946902655, "2020-06": 0.97633136094675, "2020-09": 1.3609467455621, "2020-12": 1.7011834319527, "2021-03": -3.6552748885587, "2021-06": 2.6215022091311, "2021-09": 1.7455621301775, "2021-12": 0.99112426035503, "2022-03": 1.9230769230769, "2022-06": 2.1162444113264, "2022-09": 1.5915915915916, "2022-12": 1.7091454272864, "2023-03": 2.8464977645306, "2023-06": 2.4219910846954, "2023-09": 2.3582089552239, "2023-12": 1.9728915662651, "2024-03": 3.2335329341317, "2024-06": 2.2155688622754, "2024-09": 2.8270676691729, "2024-12": 1.4285714285714, "2025-03": 3.0030487804878, "2025-06": 2.9878048780488,

INGR Revenue

Revenue of INGR over the last years for every Quarter: 2020-03: 1543, 2020-06: 1349, 2020-09: 1502, 2020-12: 1593, 2021-03: 1614, 2021-06: 1762, 2021-09: 1763, 2021-12: 1755, 2022-03: 1892, 2022-06: 2044, 2022-09: 2023, 2022-12: 1987, 2023-03: 2137, 2023-06: 2069, 2023-09: 2033, 2023-12: 1921, 2024-03: 1882, 2024-06: 1878, 2024-09: 1870, 2024-12: 1800, 2025-03: 1813, 2025-06: 1833,

Description: INGR Ingredion

Ingredion Incorporated is a leading global manufacturer and supplier of sweeteners, starches, and nutrition ingredients derived from corn and other starch-based materials. The companys diverse product portfolio caters to a wide range of industries, including food and beverages, paper, textiles, pharmaceuticals, and biomaterials.

Key Performance Indicators (KPIs) that can be used to evaluate Ingredions performance include revenue growth, gross margin expansion, and return on equity (RoE). With a RoE of 16.11%, the company demonstrates a strong ability to generate profits from shareholder equity. Additionally, the companys diversified product offerings and global presence provide a stable foundation for long-term growth.

Ingredions product segments, including sweeteners, starches, and nutrition ingredients, are used in various applications, such as food and beverage production, paper manufacturing, and pharmaceuticals. The companys ability to innovate and expand its product offerings in emerging markets, such as biomaterials, can drive future growth. Key metrics to monitor include the companys revenue mix, with a focus on higher-margin products, and its ability to maintain pricing power in a competitive market.

From a valuation perspective, Ingredions price-to-earnings (P/E) ratio of 14.18 and forward P/E of 12.30 suggest a relatively attractive valuation compared to its earnings growth prospects. Investors should monitor the companys earnings growth trajectory, as well as its ability to maintain a stable dividend payout, to assess the stocks potential for long-term returns.

INGR Stock Overview

Market Cap in USD 8,295m
Sub-Industry Agricultural Products & Services
IPO / Inception 1997-12-11

INGR Stock Ratings

Growth Rating 47.3%
Fundamental 69.8%
Dividend Rating 54.6%
Return 12m vs S&P 500 -19.6%
Analyst Rating 3.43 of 5

INGR Dividends

Dividend Yield 12m 2.47%
Yield on Cost 5y 4.60%
Annual Growth 5y -1.46%
Payout Consistency 97.7%
Payout Ratio 27.8%

INGR Growth Ratios

Growth Correlation 3m -81.4%
Growth Correlation 12m -24.2%
Growth Correlation 5y 93.1%
CAGR 5y 18.27%
CAGR/Max DD 3y 0.94
CAGR/Mean DD 3y 4.33
Sharpe Ratio 12m -0.41
Alpha -11.44
Beta 0.149
Volatility 19.47%
Current Volume 330.1k
Average Volume 20d 412.5k
Stop Loss 122.3 (-3%)
Signal 0.18

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (676.0m TTM) > 0 and > 6% of Revenue (6% = 439.0m TTM)
FCFTA 0.10 (>2.0%) and ΔFCFTA -3.76pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 30.80% (prev 24.23%; Δ 6.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.15 (>3.0%) and CFO 1.18b > Net Income 676.0m (YES >=105%, WARN >=100%)
Net Debt (926.0m) to EBITDA (1.20b) ratio: 0.77 <= 3.0 (WARN <= 3.5)
Current Ratio 2.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (65.6m) change vs 12m ago -1.80% (target <= -2.0% for YES)
Gross Margin 25.57% (prev 23.59%; Δ 1.98pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 97.53% (prev 106.8%; Δ -9.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 31.68 (EBITDA TTM 1.20b / Interest Expense TTM 31.0m) >= 6 (WARN >= 3)

Altman Z'' 6.36

(A) 0.29 = (Total Current Assets 3.52b - Total Current Liabilities 1.26b) / Total Assets 7.78b
(B) 0.69 = Retained Earnings (Balance) 5.38b / Total Assets 7.78b
(C) 0.13 = EBIT TTM 982.0m / Avg Total Assets 7.50b
(D) 1.26 = Book Value of Equity 4.43b / Total Liabilities 3.50b
Total Rating: 6.36 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 69.80

1. Piotroski 6.50pt = 1.50
2. FCF Yield 8.71% = 4.36
3. FCF Margin 10.98% = 2.74
4. Debt/Equity 0.42 = 2.41
5. Debt/Ebitda 1.49 = 0.97
6. ROIC - WACC 6.32% = 7.90
7. RoE 16.76% = 1.40
8. Rev. Trend -86.91% = -4.35
9. Rev. CAGR -3.52% = -0.59
10. EPS Trend 38.06% = 0.95
11. EPS CAGR 25.74% = 2.50

What is the price of INGR shares?

As of September 13, 2025, the stock is trading at USD 126.12 with a total of 330,125 shares traded.
Over the past week, the price has changed by -1.78%, over one month by -0.58%, over three months by -9.02% and over the past year by -4.27%.

Is Ingredion a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Ingredion (NYSE:INGR) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 69.80 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INGR is around 127.32 USD . This means that INGR is currently overvalued and has a potential downside of 0.95%.

Is INGR a buy, sell or hold?

Ingredion has received a consensus analysts rating of 3.43. Therefor, it is recommend to hold INGR.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the INGR price?

Issuer Target Up/Down from current
Wallstreet Target Price 148.7 17.9%
Analysts Target Price 148.7 17.9%
ValueRay Target Price 138.1 9.5%

Last update: 2025-08-30 04:45

INGR Fundamental Data Overview

Market Cap USD = 8.30b (8.30b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 868.0m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 12.6149
P/E Forward = 11.919
P/S = 1.1339
P/B = 1.9498
P/EG = 1.7653
Beta = 0.709
Revenue TTM = 7.32b USD
EBIT TTM = 982.0m USD
EBITDA TTM = 1.20b USD
Long Term Debt = 1.74b USD (from longTermDebt, last quarter)
Short Term Debt = 46.0m USD (from shortTermDebt, last quarter)
Debt = 1.79b USD (Calculated: Short Term 46.0m + Long Term 1.74b)
Net Debt = 926.0m USD (from netDebt column, last quarter)
Enterprise Value = 9.21b USD (8.30b + Debt 1.79b - CCE 868.0m)
Interest Coverage Ratio = 31.68 (Ebit TTM 982.0m / Interest Expense TTM 31.0m)
FCF Yield = 8.71% (FCF TTM 803.0m / Enterprise Value 9.21b)
FCF Margin = 10.98% (FCF TTM 803.0m / Revenue TTM 7.32b)
Net Margin = 9.24% (Net Income TTM 676.0m / Revenue TTM 7.32b)
Gross Margin = 25.57% ((Revenue TTM 7.32b - Cost of Revenue TTM 5.45b) / Revenue TTM)
Tobins Q-Ratio = 2.08 (Enterprise Value 9.21b / Book Value Of Equity 4.43b)
Interest Expense / Debt = 0.67% (Interest Expense 12.0m / Debt 1.79b)
Taxrate = 29.75% (277.0m / 931.0m)
NOPAT = 689.8m (EBIT 982.0m * (1 - 29.75%))
Current Ratio = 2.78 (Total Current Assets 3.52b / Total Current Liabilities 1.26b)
Debt / Equity = 0.42 (Debt 1.79b / last Quarter total Stockholder Equity 4.25b)
Debt / EBITDA = 1.49 (Net Debt 926.0m / EBITDA 1.20b)
Debt / FCF = 2.23 (Debt 1.79b / FCF TTM 803.0m)
Total Stockholder Equity = 4.03b (last 4 quarters mean)
RoA = 8.69% (Net Income 676.0m, Total Assets 7.78b )
RoE = 16.76% (Net Income TTM 676.0m / Total Stockholder Equity 4.03b)
RoCE = 17.01% (Ebit 982.0m / (Equity 4.03b + L.T.Debt 1.74b))
RoIC = 11.80% (NOPAT 689.8m / Invested Capital 5.84b)
WACC = 5.48% (E(8.30b)/V(10.08b) * Re(6.56%)) + (D(1.79b)/V(10.08b) * Rd(0.67%) * (1-Tc(0.30)))
Shares Correlation 3-Years: -48.08 | Cagr: -0.14%
Discount Rate = 6.56% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈888.6m ; Y1≈583.4m ; Y5≈266.8m
Fair Price DCF = 81.71 (DCF Value 5.24b / Shares Outstanding 64.2m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: -86.91 | Revenue CAGR: -3.52%
Rev Growth-of-Growth: -0.11
EPS Correlation: 38.06 | EPS CAGR: 25.74%
EPS Growth-of-Growth: -13.32

Additional Sources for INGR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle